Evidence map›Paper›PMID 36497771›Full record

ArticleInternational journal of environmental research and public health2022

The Validity of Benchmark Dose Limit Analysis for Estimating Permissible Accumulation of Cadmium.

Soisungwan Satarug, David A Vesey, Glenda C Gobe, Aleksandra Buha Đorđević

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Therapeutic Efficacy ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Soisungwan SatarugKidney Disease Research Collaborative, Translational Research Institute, Brisbane 4102, Australia.
David A VeseyKidney Disease Research Collaborative, Translational Research Institute, Brisbane 4102, Australia.ORCID 0000-0002-2856-6650
Glenda C GobeKidney Disease Research Collaborative, Translational Research Institute, Brisbane 4102, Australia.ORCID 0000-0002-8732-7908
Aleksandra Buha ĐorđevićDepartment of Toxicology "Akademik Danilo Soldatović", Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-6942-7040
Translational Research Institute · AUUniversity of Belgrade · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cadmium (Cd) is a toxic metal pollutant that accumulates, especially in the proximal tubular epithelial cells of kidneys, where it causes tubular cell injury, cell death and a reduction in glomerular filtration rate (GFR). Diet is the main Cd exposure source in non-occupationally exposed and non-smoking populations. The present study aimed to evaluate the reliability of a tolerable Cd intake of 0.83 μg/kg body weight/day, and its corresponding toxicity threshold level of 5.24 μg/g creatinine. The PROAST software was used to calculate the lower 95% confidence bound of the benchmark dose (BMDL) values of Cd excretion (E

Indexed as

AcetylglucosaminidaseCadmiumbeta 2-MicroglobulinBiomarkersCreatinineEnvironmental ExposureFemaleHumansMaleMiddle AgedReproducibility of ResultsAcetylglucosaminidasebeta 2-MicroglobulinBiomarkersCadmiumCreatininebenchmark doseBMDLBMD lower confidence limitBMDUBMD upper confidence limitcadmiumeGFRN-acetyl-β-D-glucosaminidaseNOAELβ2-microglobulin

Identifiers

PMID36497771
PMCPMC9736539
OpenAlexW4310375297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.